NCT02339974View on ClinicalTrials.gov

Heterotopic Implantation Of the Edwards-Sapien Transcatheter Aortic Valve in the Inferior VEna Cava for the Treatment of Severe Tricuspid Regurgitation (HOVER)

PHASE3CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 31, 2024

Study Completion Date

June 30, 2025

Conditions
Tricuspid Regurgitation
Interventions
DEVICE

Heterotopic Implantation Of the Edwards-Sapien XT Transcatheter Valve in the Inferior VEna Cava

Trial Locations (1)

48202

Henry Ford Hosptial, Detroit

All Listed Sponsors
lead

Henry Ford Health System

OTHER

NCT02339974 - Heterotopic Implantation Of the Edwards-Sapien Transcatheter Aortic Valve in the Inferior VEna Cava for the Treatment of Severe Tricuspid Regurgitation (HOVER) | Biotech Hunter | Biotech Hunter